Justia Products Liability Opinion Summaries

Articles Posted in Supreme Court of Illinois
by
Gillespie was working on a dump trailer manufactured and sold by East and leased by his employer. It was loaded with mulch. Using the front cast iron side steps, Gillespie climbed on top of the trailer and lowered himself inside. After leveling the mulch, Gillespie crawled to the front, positioned his right knee on the aluminum cap, placed his left foot on the first step, and attempted to place his right foot on the second step. His hands slid off the top of the trailer, and his left foot slipped, causing him to fall off the stairs. He landed on his feet and felt a sharp pain in his back. He reported his injury before returning to work.Gillespie alleged that East is strictly liable for, and acted negligently in, designing, manufacturing, and selling a defective and unreasonably dangerous product that lacked adequate safety features; that East failed to warn consumers about foreseeable dangers from unsafe modifications; and that the product did not undergo product testing for safety. In a deposition, Gillespie's expert, Hutter, opined that the steps were defective and unreasonably dangerous; the spacing and width of the steps and the lack of side rails did not comply with the recommended practices of the Occupational Safety and Health Administration (OSHA), the American National Standards Institute, the Federal Motor Carrier Safety Regulations, and the Truck Trailer Manufacturers Association.The circuit court granted the defendant summary judgment, ruling that OSHA does not apply to trailers, that industry standards are not mandatory, and that third-party modifications demonstrated that the trailer was not unreasonably dangerous when it left East’s control. The appellate court reversed. The Illinois Supreme Court affirmed. Hutter’s deposition testimony was sufficient to create a genuine issue of material fact as to whether the trailer was unreasonably dangerous. View "Gillespie v. Edmier" on Justia Law

by
Essure--permanent birth control for women--originally was manufactured and developed by Conceptus, a California corporation. Bayer bought Conceptus. Bayer marketed Essure as safer and more effective than other birth control. Two residents of Madison County, Illinois, filed personal injury complaints, alleging that Essure caused debilitating pain, heavy bleeding that necessitated medication, and autoimmune disorders. including 179 plaintiffs from at least 25 states. Months later, the U.S. Supreme Court issued its “Bristol-Myers” decision. Bayer argued that, following Bristol-Myers, a court cannot exercise specific personal jurisdiction over an out-of-state defendant as to the claims of out-of-state plaintiffs when the conduct giving rise to the claims did not occur in the forum state. The plaintiffs argued Illinois courts had specific personal jurisdiction over Bayer because it “created the Essure Accreditation Program and the marketing strategy for Essure in Illinois,” conducted clinical trials in Illinois, and used Illinois as a testing ground for its physician training program. The appellate court affirmed the denials of motions to dismiss: Bayer “conducted a part of its general business in Illinois, and [p]laintiffs’ claims arose out of" trials conducted, in part, in Illinois.The Illinois Supreme Court reversed. The nonresident plaintiffs identified no jurisdictionally relevant links between their claims and Illinois. The nonresidents have not explained how Illinois could be a convenient location for this litigation; they were not implanted with their devices here and have identified no other activity that would connect their specific claims to Illinois. Many nonresident plaintiffs initiated duplicate actions in California, indicating that the interests of judicial economy are not furthered by permitting their claims to proceed in Illinois. A corporation’s continuous activity of some sort within a state is not enough to render the corporation subject to suits unrelated to that activity. View "Rios v. Bayer Corp." on Justia Law

by
In 2013, the Joneses sought to recover damages suffered when John contracted lung cancer, resulting from his exposure to “asbestos from one or more” of numerous companies while he was involved in the construction industry and while he repaired the brakes on motor vehicles he owned. Owens and Abex were among the named defendants. The Joneses asserted that the defendants knew that asbestos was dangerous but conspired to misrepresent its dangers and to falsely represent that exposure to asbestos and asbestos-containing products was safe or nontoxic. Abex and Owens argued that the civil conspiracy claims were based on the same facts as those advanced unsuccessfully by other plaintiffs in numerous earlier cases, particularly the Illinois Supreme Court’s 1999 McClure decision. The circuit court entered summary judgment in favor of the defendants. The appellate court reversed.The Illinois Supreme Court reversed and remanded. Instead of undertaking a meaningful evaluation of the applicability of the legal principles governing civil conspiracy as articulated in the cited precedent, and with no real assessment of whether and to what extent any factual differences between those cases and this one might justify a different result, the appellate court summarily distinguished the prior decisions on the sole grounds that the civil conspiracy claims advanced against Owens and Abex in those cases were decided in the context of motions for judgment notwithstanding the verdict, while here they were resolved on motions for summary judgment. View "Jones v. Pneumo Abex LLC" on Justia Law

by
In this strict product liability action, the Supreme Court of Illinois affirmed the appellate court's judgment and remanded to the trial court for its determination of whether the manufacturer of flexible bulk containers, Taihua Group, "is unable to satisfy a judgment as determined by the court," as mandated by section 2-621(b)(4) of the Illinois Code of Civil Procedure.The court rejected the "bankrupt or nonexistent" standard for reinstatement under section 2-621(b)(4) promulgated in Chraca v. U.S. Battery Manufacturing Co., 2014 IL App (1st) 132325, and overruled that decision. Rather, the court read the statute to permit the trial court to rely on a broader range of factors to determine if a particular manufacturer is "unable to satisfy" the judgment against it. View "Cassidy v. China Vitamins, LLC" on Justia Law